These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 24379240)
1. EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer. Bradley A; Zheng H; Ziebarth A; Sakati W; Branham-O'Connor M; Blumer JB; Liu Y; Kistner-Griffin E; Rodriguez-Aguayo C; Lopez-Berestein G; Sood AK; Landen CN; Eblen ST Carcinogenesis; 2014 May; 35(5):1100-9. PubMed ID: 24379240 [TBL] [Abstract][Full Text] [Related]
2. MCT1 promotes the cisplatin-resistance by antagonizing Fas in epithelial ovarian cancer. Yan C; Yang F; Zhou C; Chen X; Han X; Liu X; Ma H; Zheng W Int J Clin Exp Pathol; 2015; 8(3):2710-8. PubMed ID: 26045776 [TBL] [Abstract][Full Text] [Related]
3. The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. O'Brien PM; Davies MJ; Scurry JP; Smith AN; Barton CA; Henderson MJ; Saunders DN; Gloss BS; Patterson KI; Clancy JL; Heinzelmann-Schwarz VA; Murali R; Scolyer RA; Zeng Y; Williams ED; Scurr L; Defazio A; Quinn DI; Watts CK; Hacker NF; Henshall SM; Sutherland RL Br J Cancer; 2008 Mar; 98(6):1085-93. PubMed ID: 18349819 [TBL] [Abstract][Full Text] [Related]
4. HOTAIR is a potential target for the treatment of cisplatin‑resistant ovarian cancer. Wang Y; Wang H; Song T; Zou Y; Jiang J; Fang L; Li P Mol Med Rep; 2015 Aug; 12(2):2211-6. PubMed ID: 25824616 [TBL] [Abstract][Full Text] [Related]
5. Differential activation of NF-κB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells. Gaikwad SM; Thakur B; Sakpal A; Singh RK; Ray P Int J Biochem Cell Biol; 2015 Apr; 61():90-102. PubMed ID: 25681684 [TBL] [Abstract][Full Text] [Related]
6. [Effect of XPG down-regulation gene expression towards the proliferation of epithelial ovarian cancer cells and its chemosensitivity to platinum]. Zhang W; Wu FX; Wang Q; Li L Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):286-91. PubMed ID: 22781116 [TBL] [Abstract][Full Text] [Related]
7. Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells. Zhang R; Shi H; Ren F; Li X; Zhang M; Feng W; Jia Y Oncol Rep; 2016 Apr; 35(4):2466-72. PubMed ID: 26794135 [TBL] [Abstract][Full Text] [Related]
8. 4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway. Liu M; Bamodu OA; Huang WC; Zucha MA; Lin YK; Wu ATH; Huang CC; Lee WH; Yuan CC; Hsiao M; Deng L; Tzeng YM; Yeh CT Toxicol Appl Pharmacol; 2017 Jun; 325():48-60. PubMed ID: 28408137 [TBL] [Abstract][Full Text] [Related]
9. [Cisplatin resistant effects of dihydrofolate reductase gene expression up-regulation in epithelial ovarian cancer]. Li Z; Wang Q; Zhang W; Yang Z; Li L Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):854-60. PubMed ID: 26887775 [TBL] [Abstract][Full Text] [Related]
10. Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer. Ziebarth AJ; Nowsheen S; Steg AD; Shah MM; Katre AA; Dobbin ZC; Han HD; Lopez-Berestein G; Sood AK; Conner M; Yang ES; Landen CN Clin Cancer Res; 2013 Jan; 19(1):170-82. PubMed ID: 23147994 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic Targeting of ATP7B in Ovarian Carcinoma. Mangala LS; Zuzel V; Schmandt R; Leshane ES; Halder JB; Armaiz-Pena GN; Spannuth WA; Tanaka T; Shahzad MM; Lin YG; Nick AM; Danes CG; Lee JW; Jennings NB; Vivas-Mejia PE; Wolf JK; Coleman RL; Siddik ZH; Lopez-Berestein G; Lutsenko S; Sood AK Clin Cancer Res; 2009 Jun; 15(11):3770-80. PubMed ID: 19470734 [TBL] [Abstract][Full Text] [Related]
12. Targeting c-MYC in Platinum-Resistant Ovarian Cancer. Reyes-González JM; Armaiz-Peña GN; Mangala LS; Valiyeva F; Ivan C; Pradeep S; Echevarría-Vargas IM; Rivera-Reyes A; Sood AK; Vivas-Mejía PE Mol Cancer Ther; 2015 Oct; 14(10):2260-9. PubMed ID: 26227489 [TBL] [Abstract][Full Text] [Related]
13. HDAC1 Silencing in Ovarian Cancer Enhances the Chemotherapy Response. Liu X; Yu Y; Zhang J; Lu C; Wang L; Liu P; Song H Cell Physiol Biochem; 2018; 48(4):1505-1518. PubMed ID: 30071534 [TBL] [Abstract][Full Text] [Related]
14. Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis. Simonin K; N'Diaye M; Lheureux S; Loussouarn C; Dutoit S; Briand M; Giffard F; Brotin E; Blanc-Fournier C; Poulain L Apoptosis; 2013 Apr; 18(4):492-508. PubMed ID: 23344663 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous targeting of ATM and Mcl-1 increases cisplatin sensitivity of cisplatin-resistant non-small cell lung cancer. Zhang F; Shen M; Yang L; Yang X; Tsai Y; Keng PC; Chen Y; Lee SO; Chen Y Cancer Biol Ther; 2017 Aug; 18(8):606-615. PubMed ID: 28686074 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic Regulation of the Homeobox Gene MSX1 Associates with Platinum-Resistant Disease in High-Grade Serous Epithelial Ovarian Cancer. Bonito NA; Borley J; Wilhelm-Benartzi CS; Ghaem-Maghami S; Brown R Clin Cancer Res; 2016 Jun; 22(12):3097-3104. PubMed ID: 26763252 [TBL] [Abstract][Full Text] [Related]
17. MiR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells. Rao YM; Shi HR; Ji M; Chen CH J Huazhong Univ Sci Technolog Med Sci; 2013 Aug; 33(4):567-572. PubMed ID: 23904379 [TBL] [Abstract][Full Text] [Related]
18. Ubiquitin E3 ligase CRL4(CDT2/DCAF2) as a potential chemotherapeutic target for ovarian surface epithelial cancer. Pan WW; Zhou JJ; Yu C; Xu Y; Guo LJ; Zhang HY; Zhou D; Song FZ; Fan HY J Biol Chem; 2013 Oct; 288(41):29680-91. PubMed ID: 23995842 [TBL] [Abstract][Full Text] [Related]
19. Rab25 is responsible for phosphoinositide 3-kinase/AKT‑mediated cisplatin resistance in human epithelial ovarian cancer cells. Fan Y; Wang L; Han X; Liu X; Ma H Mol Med Rep; 2015 Mar; 11(3):2173-8. PubMed ID: 25405658 [TBL] [Abstract][Full Text] [Related]
20. Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins. Tanaka N; Patel AA; Wang J; Frederick MJ; Kalu NN; Zhao M; Fitzgerald AL; Xie TX; Silver NL; Caulin C; Zhou G; Skinner HD; Johnson FM; Myers JN; Osman AA Clin Cancer Res; 2015 Nov; 21(21):4831-44. PubMed ID: 26124202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]